论文部分内容阅读
目的:分析前列地尔联合肾康注射液治疗老年人慢性肾衰竭的临床疗效。方法:选取2014年7月到2015年7月我院收治的老年慢性肾衰竭患者30例作为对照组,给予常规治疗方法;选取同期同类型患者30例作为研究组,给予前列地尔联合肾康注射液治疗方法。对两组患者的临床治疗效果进行分析和对比。结果:给予两种不同的治疗方法后,研究组治疗总体有效率高于对照组(P<0.05);研究组不良反应率显著低于对照组(P<0.05)。讨论:对老年人慢性肾衰竭患者采用前列地尔联合肾康注射液治疗方法,效果显著,该方法值得在临床医学上大力推广使用。
Objective: To analyze the clinical efficacy of alprostadil plus Shenkang injection in the treatment of chronic renal failure in the elderly. Methods: From July 2014 to July 2015, 30 elderly patients with chronic renal failure admitted to our hospital were enrolled as control group and received routine treatment. Thirty patients of the same type in the same period were selected as study group, Injection therapy. The clinical effects of two groups of patients were analyzed and compared. Results: After giving two different treatment methods, the total effective rate of the study group was higher than that of the control group (P <0.05). The adverse reaction rate of the study group was significantly lower than that of the control group (P <0.05). Discussion: The elderly patients with chronic renal failure with alprostadil combined Shenkang injection treatment, the effect is significant, the method deserves to be widely promoted in clinical medicine.